BMRN

#761
BioMarin Pharmaceutical Inc. - Common Stock
57.2 9 USD
+8.77%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
57.29
57.29
Faixa anual
49.26
66.28
Mudança diária
+8.77%
Mudança mensal
+5.60%
Mudança em 6 meses
+3.23%
Mudança anual
-2.02%
Fechamento anterior
52.6 7
Open
57.2 9
Mínimo
57.2 9
High
57.2 9
Volume
194
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 11.07 B
  • Employee 3 221
  • Founded N/A
  • CEO Alexander Hardy
  • Website www.biomarin.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZWZ05
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
33.02
Índice preço/fluxo de caixa
3.64

BioMarin Pharmaceutical Inc. - Common Stock

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Notícias